Pharmafile Logo
Pharmafocus logo
Advanced Search

Medical Communications

Showing 15 posts of 6402 posts found.

NICE recommends Pfizer’s Xeljanz for juvenile idiopathic arthritis

September 10, 2021 Medical Communications

NICE has published final draft guidance recommending the use of Pfizer’s Xeljanz (tofacitinib) as an option for treating active polyarticular …
News

Pfizer and AstraZeneca approved as booster COVID vaccines

September 10, 2021 Medical Communications

The MHRA has approved the use of Pfizer and AstraZeneca’s COVID-19 vaccines for the planned booster programme this winter. However, …
News
nhs_old_hospital_1

NHS lung cancer patients to receive Amgen’s tumour-stopping drug

September 10, 2021 Medical Communications, Research and Development

NHS patients will be the first in Europe to receive a new drug that can prevent lung cancer tumour growth, …
News

FDA grants Fast Track Designation for Vor Biopharma’s AML drug

September 10, 2021 Medical Communications, Research and Development

Vor Biopharma has announced that the FDA has granted their acute myeloid leukemia (AML) engineered hematopoietic stem cell therapy (eHSC), …
News

Trials of former Theranos CEO Elizabeth Holmes are underway

September 8, 2021 Medical Communications, Research and Development

The highly anticipated trials of Elizabeth Holmes, founder and former CEO of the now-defunct Theranos, have commenced. Prosecutors are to …
News

Wider use of SGLT2 inhibitors for CVD recommended by NICE

September 7, 2021 Manufacturing and Production, Medical Communications

NICE has updated its guidelines on the management of type 2 diabetes, recommending wider use of SGLT2 inhibitors in those …
News

FDA halts BioMarin’s PKU gene therapy trial

September 7, 2021 Manufacturing and Production, Medical Communications, Research and Development

BioMarin Pharma has announced that the FDA has slapped a clinical hold on its Phase 1/2 trial of its candidate …
News

Sinovac booster jab reverses antibody drop from Delta variant, study finds

September 6, 2021 Medical Communications, Research and Development, Sales and Marketing

Researchers have found that a booster shot of Sinovac’s COVID-19 vaccine reverses a decline in antibody activities against the Delta …
News

COVID vaccine passports to start in England this month

September 6, 2021 Medical Communications, Sales and Marketing

The Vaccine Minister, Nadhim Zahawi, has confirmed that vaccine passports will be required in nightclubs and other indoor venues at …
News

WHO: Number of dementia sufferers to rise 40% to 78 million by 2030

September 3, 2021 Medical Communications

A new report from the WHO has predicted the number of people suffering from dementia is set to rise by …
News

NICE approves secukinumab for young people with severe plaque psoriasis

September 3, 2021 Medical Communications

NICE has approved secukinumab (Cosentyx) as an option for treating moderate to severe plaque psoriasis in people aged six to …
News

Novartis halts kidney transplant drug trial

September 3, 2021 Medical Communications

Novartis has announced that trials investigating CFZ533 (iscalimab) in kidney transplant patients has been halted after interim data show it …
News
astrazeneca_sign_sky

AstraZeneca’s Ultomiris approved for use on children in EU

September 3, 2021 Medical Communications, Research and Development

AstraZeneca has gained EU approval for its rare blood disorder drug, Ultomiris, for use in children. The drug was developed …
News

US Congress to investigate FDA’s approval of Biogen’s Alzheimer’s drug

September 3, 2021 Medical Communications

The US Congress has requested data and documents from the FDA in relation to its accelerated approval of the controversial …
News

Risk of long COVID halved by vaccines, study finds

September 2, 2021 Medical Communications

Researchers at King’s College London have found that being fully vaccinated against COVID-19 not only cuts the risk of catching …
News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025